CAMX:STO
Camurus AB
SEKÂ 740.00
arrow_upward
+1.02%(+7.50) 1D
Nov 19, 5:29:47 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
SEKÂ 732.50
High
SEKÂ 743.50
Low
SEKÂ 728.50
Mkt. cap
44.36B
Avg. vol.
103.24K
Volume
75.36K
52-wk high
SEKÂ 750.00
52-wk low
SEKÂ 430.80
Shares outstanding
60.56M
No. of employees
323
Open
SEKÂ 732.50
High
SEKÂ 743.50
Low
SEKÂ 728.50
Mkt. cap
44.36B
Avg. vol.
103.24K
Volume
75.36K
52-wk high
SEKÂ 750.00
52-wk low
SEKÂ 430.80
Shares outstanding
60.56M
No. of employees
323
News stories
From web sources and news partners
ChartMill
·
1 hour ago
S&P 500 Gap Movers: Today's Gap-Up and Gap-Down Stocks
TradingView
·
3 hours ago
Stock Market Today: Dow, S&P 500, Nasdaq 100 Futures Rise as Wall Street Awaits Anthropic’s Listing— PANW, NTES, SLS in Focus (UPDATED)
BigGo Finance
·
6 hours ago
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
JournalArta
·
32 minutes ago
Joachim Klement to Sell Stocks After S&P 500 Signal
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB
CEOFredrik Tiberg
Employees323
Founded1991
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecamurus.com